2023-12-26
雅法交易点评-YAFO Transaction Comments
1. Summary of the week
From December 15 to 22, 2023, there are 13 Licensing deals globally including Licensing deals in China. Specifically, there are 3 Out-licensing deals; 2 Domestic deals; and 3 overseas deals. The top out-licensing for the week is the deal between Hansoh Pharmaceutical and GSK amounting to $1,710 million total potential consideration including an upfront payment of $185m and development milestone payments of up to $1,525m, along with royalties on net sales.
1a. China section
1b. Global section
2. Top Deals of the Year 2023
About YAFO Capital
Jaffa Capital was established in 2013. As a new investment and investment banking consulting institution, it is committed to investment, financing services, product introduction, and asset incubation of Chinese and overseas biomedical projects. Jaffa ranks first in the number of transactions in the field of biopharmaceutical cross-border licensing and M&A business in the past three years. Its subsidiary Jaffa Fund cooperates with pharmaceutical companies to conduct asset investments and mergers and acquisitions. Jaffa Global Medical focuses on cross-border and domestic licensing transactions of pharmaceutical products. Based on Jaffa’s extensive global network of contacts and resources, it has successfully promoted a large number of overseas projects to enter the Chinese market in the past decade and assisted many Chinese products in completing overseas authorizations. Jaffa has an experienced global transaction team covering major global pharmaceutical innovation regions such as the United States, Japan, and Europe. The core partners are all senior Wall Street investment bankers or have experience in multinational pharmaceutical companies, providing strong support for client transactions. Jaffa is headquartered in Shanghai and has branches in London, Los Angeles, Tokyo, Milan, Cambridge, and other places.
Founded in 2013, YAFO Capital is a Shanghai-based boutique investment and advisory firm, with professional team in our China, U.S., and London offices. Partnering with Pharmaceutical companies, YAFO Fund mainly invests in global assets. YAFO Life Sciences is a leading advisory boutique focused on asset transactions. YAFO has built a strong proven track record and closed dozens of in-licensing and out-licensing transactions with global pharma and biotech companies. YAFO has been ranked as the No. 1 advisor for China cross-border licensing transactions in the past three years. For more information, please visit http://www.yafocapital.com
Event Preview–ACCESS CHINA
“ACCESS CHINA” 2024 Trading Forum (Winter) will be held during the JPM conference, including online roadshows, on-site 1X1 meetings, and East-Meet-West Dinner, for domestic and overseas licensing needs pharmaceutical companies provide one-on-one, face-to-face communication opportunities with global partners. The Yaotong China@JPM2024 Forum will be held in San Francisco and online in January 2024. We will invite BD personnel from Europe, the United States, Japan, South Korea, and emerging markets (including Southeast Asia, the Middle East, and Latin America) to participate in the forum to help China Pharmaceutical companies are moving towards a broader market. Due to limited seats, in order to ensure that you can participate in this event, we sincerely invite you to register as early as possible. The final confirmation of participation is subject to the organizer’s notification letter of participation. Looking forward to meeting all my colleagues in San Francisco!
For more registration information, please click Continuous recruitment… JPM China@JPM 2024 joins hands with global partners to build the future of medical innovation
We are honored to invite you to join our “ACCESS CHINA Partnering Forum” during JPM week in January 2024. During this event, we will host Online Showcases for international and China biotech companies for presentations, Dinner Reception to gather senior management from both international and China pharma for networking and 1×1 meetings to YAFO clients for partnering opportunities. ACCESS CHINA Partnering Forum will help biotechs/pharmas efficiently present their assets in front of 500+ healthcare companies and VCs online. Audiences can have access to innovative biopharmas and healthcare products from worldwide. We look forward to welcoming you at our Partnering Forum in January!
For more information, please visit: https://biotochina.org/2023/11/10/access-china-partnering-forum-jpm-2024/
Scan the QR code to
register
Add a Xiaoyaotong assistant and apply to join the Yaotong China event and roadshow group:
BioToChina.org 